← Back to feedRead original →
VERIFIEDMint Companies·neutral
Sun Pharma plans ₹10,000 crore bond sale to refinance Organon acquisition loan: Report
AI Summary
- ·Sun Pharma plans to raise ₹10,000 crore through a bond sale.
- ·The funds will be used to refinance a loan taken for the Organon acquisition.
- ·The company previously secured an $12 billion bridge loan for the acquisition.